Search Results - "Pisani, Carol van Haelst"

Administration of Interleukin-2 (IL-2) Results in Increased Plasma Concentrations of IL-5 and Eosinophilia in Patients With Cancer by Pisani, Carol van Haelst, Kovach, John S., Kita, Hirohito, Leiferman, Kristin M., Gleich, Gerald J., Silver, Jon E., Dennin, Robert, Abrams, John S.

“…Peripheral eosinophilia is almost invariably observed during the course of interleukin-2 (IL-2) therapy and is frequently accompanied by the development of a…”
Get full text

A phase II study of recombinant human alpha-interferon in advanced hormone-refractory prostate cancer by van Haelst-Pisani, C M, Richardson, R L, Su, J, Buckner, J C, Hahn, R G, Frytak, S, Kvols, L K, Burch, P A

“…To determine the efficacy of recombinant human leukocyte alpha-interferon (IFL-RA) in advanced hormone-refractory prostate cancer, the authors treated 40…”
Get more information

Does histologic grade in soft tissue sarcoma influence response rate to systemic chemotherapy? by van Haelst-Pisani, C M, Buckner, J C, Reiman, H M, Schaid, D J, Edmonson, J H, Hahn, R G

“…To assess whether chemosensitivity in metastatic soft tissue sarcoma (STS) is influenced by the histologic grade of the tumor, the authors retrospectively…”
Get more information

Phase I and clinical pharmacological evaluation of pirozantrone hydrochloride (oxantrazole) by AMES, M. M, LOPRINZI, C. L, COLLINS, J. M, VAN HAELST-PISANI, C, RICHARDSON, R. L, RUBIN, J, MOERTEL, C. G

“…Pirozantrone hydrochloride, an anthrapyrazole analogue, was selected for clinical evaluation based on broad antitumor activity against murine tumor systems and…”
Get full text

Phase I trial of combined recombinant interleukin-2 with levamisole in patients with advanced malignant disease by Call, T G, Creagan, E T, Frytak, S, Buckner, J C, van Haelst-Pisani, C, Homburger, H A, Katzmann, J A

“…A Phase I study of rIL-2 and levamisole was performed to evaluate the activity, toxicity, and effect on immune parameters of this combination of agents in…”
Get more information

Cytoplasmic alkalinization produced by the combination of anti-immunoglobulin antibody plus cytochalasin D in murine B lymphocytes by van Haelst-Pisani, C, Cragoe, Jr, E J, Rothstein, T L

“…The intracellular pH of murine splenic B lymphocytes was measured using the pH-sensitive fluorescent dye, bis(carboxyethyl)carboxyfluorescein (BCECF). After…”
Get more information

Cancer immunotherapy: current status of treatment with interleukin 2 and lymphokine-activated killer cells by van Haelst-Pisani, C M, Pisani, R J, Kovach, J S

“…In recent years, the medical community has witnessed a growing interest in the use of adoptive immunotherapy in patients with malignant lesions refractory to…”
Get more information